Zarrei, Mehdi
Burton, Christie L.
Engchuan, Worrawat
Young, Edwin J. http://orcid.org/0000-0003-4882-6752
Higginbotham, Edward J. http://orcid.org/0000-0003-1881-9308
MacDonald, Jeffrey R. http://orcid.org/0000-0001-5058-2393
Trost, Brett http://orcid.org/0000-0003-4863-7273
Chan, Ada J. S.
Walker, Susan
Lamoureux, Sylvia
Heung, Tracy
Mojarad, Bahareh A.
Kellam, Barbara
Paton, Tara
Faheem, Muhammad
Miron, Karin
Lu, Chao
Wang, Ting
Samler, Kozue
Wang, Xiaolin
Costain, Gregory
Hoang, Ny
Pellecchia, Giovanna http://orcid.org/0000-0003-4747-3473
Wei, John
Patel, Rohan V. http://orcid.org/0000-0001-8674-9706
Thiruvahindrapuram, Bhooma
Roifman, Maian
Merico, Daniele
Goodale, Tara
Drmic, Irene
Speevak, Marsha
Howe, Jennifer L.
Yuen, Ryan K. C. http://orcid.org/0000-0001-7273-4968
Buchanan, Janet A.
Vorstman, Jacob A. S.
Marshall, Christian R. http://orcid.org/0000-0002-4003-7671
Wintle, Richard F. http://orcid.org/0000-0003-1987-1095
Rosenberg, David R.
Hanna, Gregory L.
Woodbury-Smith, Marc
Cytrynbaum, Cheryl http://orcid.org/0000-0002-3742-1250
Zwaigenbaum, Lonnie
Elsabbagh, Mayada
Flanagan, Janine
Fernandez, Bridget A.
Carter, Melissa T.
Szatmari, Peter
Roberts, Wendy
Lerch, Jason
Liu, Xudong
Nicolson, Rob http://orcid.org/0000-0001-7086-7038
Georgiades, Stelios
Weksberg, Rosanna
Arnold, Paul D.
Bassett, Anne S.
Crosbie, Jennifer
Schachar, Russell
Stavropoulos, Dimitri J.
Anagnostou, Evdokia
Scherer, Stephen W. http://orcid.org/0000-0002-8326-1999
Article History
Received: 6 May 2019
Accepted: 5 September 2019
First Online: 7 October 2019
Competing interests
: S.W.S. serves on the Scientific Advisory Committees of Population Bio and Deep Genomics; intellectual property originating from his research and held at the Hospital for Sick Children is licensed to Lineagen, and separately Athena Diagnostics. D.M. is a full-time employee of Deep Genomics and is entitled to a stock option. R.J.S., P.D.A., and J.C. consult for Highland Therapeutics. Intellectual property from ADHD research at the Hospital for Sick Children is licensed to Ehave and the National Research Council of Canada. Other authors declare no competing interests for the data and interpretation presented in this study. R.J.S., P.D.A., and J.C. consults for Highland Therapeutics. Intellectual property from their research at the Hospital for Sick Children is licensed to Ehave and the National Research Council. D.M. is a full-time employee of Deep Genomics and is entitled to stock options. S.W.S. is on the Scientific Advisory Committees of Population Bio and Deep Genomics; intellectual property from his research held at the Hospital for Sick Children is licensed to Athena Diagnostics, and separately to Lineagen. These relationships did not influence data interpretation or presentation during this study, but are disclosed for potential future consideration.